How much longer will the popular weight loss medications be in shortage, and what happens in your med spa when they can no longer be compounded? This week, AmSpa founder and CEO, Alex R. Thiersch, JD, is joined by Sam Pondrom, JD, associate at national healthcare law firm ByrdAdatto. They talk about the recent availability status updates for tirzepatide and semaglutide, and what changes medical spas can anticipate when the brand-name medications become fully available. Listen to hear more about:

• What the latest changes in the status of tirzepatide availability mean and don’t mean;

Catch up on AmSpa’s coverage for the changing tirzepatide status and semaglutide usage in med spas.

Music by Ghost Score